Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Oxidative Stress And Dermal Toxicity Of Iron Oxide Nanoparticles In Vitro

A. Murray, E. Kisin, A. Inman, S. Young, M. Muhammed, T. Burks, A. Uheida, A. Tkach, Micah J. Waltz, V. Castranova, B. Fadeel, V. Kagan, J. Riviere, N. Monteiro-Riviere, A. Shvedova
Published 2012 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
A number of commercially available metal/metal oxide nanoparticles (NPs) such as superparamagnetic iron oxide (SPION) are utilized by the medical field for a wide variety of applications. These NPs may able to induce dermal toxicity via their physical nature and reactive surface properties. We hypothesize that SPION may be toxic to skin via the ability of particles to be internalized and thereby initiate oxidative stress, inducing redox-sensitive transcription factors affecting/leading to inflammation. Due to the skin’s susceptibility to UV radiation, it is also of importance to address the combined effect of UVB and NPs co-exposure. To test this hypothesis, the effects of dextran-coated SPION of different sizes (15–50 nm) and manufacturers (MicroMod, Rostock-Warnemunde, Germany and KTH-Royal Institute of Technology, Stockholm, Sweden) were evaluated in two cell lines: normal human epidermal keratinocytes (HEK) and murine epidermal cells (JB6 P+). HEK cells exposed to 20 nm (KTH and MicroMod) had a decrease in viability, while the 15 and 50 nm particles were not cytotoxic. HEK cells were also capable of internalizing the KTH particles (15 and 20 nm) but not the MicroMod SPION (20 and 50 nm). IL-8 and IL-6 were also elevated in HEK cells following exposure to SPION. Exposure of JB6 P+ cells to all SPIONs evaluated resulted in activation of AP-1. Exposure to SPION alone was not sufficient to induce NF-κB activation; however, co-exposure with UVB resulted in significant NF-κB induction in cells exposed to 15 and 20 nm KTH SPION and 50 nm MicroMod particles. Pre-exposure of JB6 P+ cells to UVB followed by NPs induced a significant depletion of glutathione, release of cytokines, and cell damage as assessed by release of lactate dehydrogenase. Altogether, these data indicate that co-exposure to UVB and SPIONs was associated with induction of oxidative stress and release of inflammatory mediators. These results verify the need to thoroughly evaluate the adverse effects of UVB when evaluating dermal toxicity of engineered NPs on skin.
This paper references
10.1007/s00330-004-2405-2
Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
S. Metz (2004)
10.1016/J.BIOMATERIALS.2003.12.046
Cell response to dextran-derivatised iron oxide nanoparticles post internalisation.
C. Berry (2004)
10.1016/j.biomaterials.2009.09.093
Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles.
O. Ziv-Polat (2010)
10.1002/(SICI)1097-4547(19970415)48:2<168::AID-JNR9>3.0.CO;2-A
Activation of CPP32 during apoptosis of neurons and astrocytes
R. Keane (1997)
10.1016/S0142-9612(03)00237-0
Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro.
C. Berry (2003)
10.1073/PNAS.88.10.4328
Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro.
M. Toledano (1991)
10.1046/J.1523-1747.2003.12418.X
Pigmented melanocytes are protected against ultraviolet-A-induced membrane damage.
E. Kvam (2003)
Encounters with Fos and Jun on the road to AP-1.
C. Abate (1990)
10.1016/0140-6736(91)92168-2
Keratinocytes as initiators of inflammation
J. Barker (1991)
The nature of photoaging: its prevention and repair.
L. Kligman (1986)
10.1016/0009-2797(94)90029-9
Regulation of the transcription factors NF-κB and AP-1 by redox changes
M. Meyer (1994)
10.1021/bc800209u
Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines.
A. L. Martin (2008)
10.1111/j.1751-1097.1987.tb04759.x
POTENTIAL INVOLVEMENT OF FREE RADICAL REACTIONS IN ULTRAVIOLET LIGHT‐MEDIATED CUTANEOUS DAMAGE *
H. Black (1987)
10.1080/MCCM.6.4.177.187
Glutathione depletion is associated with augmenting a proinflammatory signal: evidence for an antioxidant/pro-oxidant mechanism regulating cytokines in the alveolar epithelium.
J. Haddad (2000)
10.1016/0962-8924(91)90072-H
A role for oxygen radicals as second messengers.
R. Schreck (1991)
Photo-oxidative skin damage and antioxidants.
Y. Miyachi (1990)
10.1186/cc1839
Science review: Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for nuclear factor-κB
J. Haddad (2002)
10.1002/smll.200800646
Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles.
O. Veiseh (2009)
10.1016/S0891-5849(98)00132-4
Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation.
J. Fuchs (1998)
10.1021/JA0422155
Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging.
Y. Jun (2005)
10.1023/B:JMSM.0000021126.32934.20
Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture
A. Gupta (2004)
Cell Biochem Biophys
(2013)
10.1007/s001170050053
Entwicklung und experimenteller Einsatz von rezeptorspezifischen MR-Kontrastmitteln
P. Reimer (2012)
10.1016/S0898-6568(02)00053-0
Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors.
J. Haddad (2002)
10.1002/JMRI.1880070629
Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages
A. Moore (1997)
10.1046/j.1365-2133.1998.02062.x
Topical application of α‐tocopherol modulates the antioxidant network and diminishes ultraviolet‐induced oxidative damage in murine skin
Lopez‐Torres (1998)
10.1016/0092-8674(91)90241-P
Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity
W. Boyle (1991)
10.1016/0003-2697(92)90317-Z
Determining the effect of inducible protein phosphorylation on the DNA-binding activity of transcription factors.
A. Papavassiliou (1992)
10.1080/15416518.2013.781402
Theory to Practice: Practice to Theory
Devi Akella (2013)
10.1007/978-94-015-9576-6
Nanotechnology Research Directions: IWGN Workshop Report
M. Roco (2000)
10.1300/J021V03N02_09
Theory to practice: the elusive marriage.
P. L. Shepherd (1982)
10.1530/REP.0.1210753
Mechanisms of cytokine-induced death of cultured bovine luteal cells.
M. Petroff (2001)
10.1148/RADIOLOGY.175.2.2326474
Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.
R. Weissleder (1990)
10.1016/S0891-5849(99)00177-X
Glutathione and its role in cellular functions.
H. Sies (1999)
10.1016/S0142-9612(02)00440-4
Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating.
C. Wilhelm (2003)
10.1038/nm1101-1241
Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent
M. Zhao (2001)
10.2214/AJR.152.1.167
Superparamagnetic iron oxide: pharmacokinetics and toxicity.
R. Weissleder (1989)
10.1002/nbm.1260
Macrophage physiological function after superparamagnetic iron oxide labeling
J. Hsiao (2008)
10.1016/S0891-5849(01)00480-4
Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple.
F. Q. Schafer (2001)
10.1787/eco_surveys-hun-2012-graph45-en
Health risks.
J. Longstreth (1998)
10.3109/02652049609026013
Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution.
C. Chouly (1996)
[Iron oxides as contrast agents for MRI of the liver].
B. V. van Beers (1995)
10.1016/0730-725X(95)00024-B
Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
C. W. Jung (1995)
10.1097/00004424-199510000-00006
Cellular Uptake and Trafficking of a Prototypical Magnetic Iron Oxide Label In Vitro
E. Schulze (1995)
10.1046/J.1523-1747.2000.00865.X
Redox cycling of phenol induces oxidative stress in human epidermal keratinocytes.
A. Shvedova (2000)
[Development and experimental use of receptor-specific MR contrast media].
P. Reimer (1996)
10.1007/BF00203614
The role of vitamin E in normal and damaged skin
F. Nachbar (2004)
10.1111/1523-1747.EP12374036
Free radicals in cutaneous biology.
D. Darr (1994)
netic nanoparticle design for medical diagnosis and therapy
S. Mornet (2004)
10.1016/J.BIOMATERIALS.2006.12.003
Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro.
K. Mueller (2007)
Thiol regulation of the production of TNF-alpha, IL-6 and IL-8 by human alveolar macrophages.
P. Gosset (1999)
10.1001/ARCHDERM.1991.01680050115015
The cytokine network in psoriasis.
B. Nickoloff (1991)
10.1093/annhyg/43.1.7
Mechanisms and mediators in coal dust induced toxicity: a review.
R. Schins (1999)
10.1038/sj.onc.1203128
Role of redox potential and reactive oxygen species in stress signaling
V. Adler (1999)
10.1016/S0165-2427(02)00136-8
Keratinocytes and cytokines.
A. Gröne (2002)
10.1016/J.ADDR.2006.09.013
Recent advances in iron oxide nanocrystal technology for medical imaging.
C. Corot (2006)
10.1016/0304-8853(93)91113-L
Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer
D. Chan (1993)
Development and experimental application of receptor-specific
P. Reimer (1996)
10.1016/j.jneuroim.2005.11.011
Cytokine profile of iron-laden macrophages: Implications for cellular magnetic resonance imaging
Ines Siglienti (2006)
10.1089/15230860260220175
Oxidative stress and its role in skin disease.
K. Trouba (2002)
10.1038/73219
In vivo magnetic resonance imaging of transgene expression
R. Weissleder (2000)
10.1021/JA052337C
In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals.
Y. Huh (2005)
10.1016/1011-1344(92)85086-A
Skin photosensitizing agents and the role of reactive oxygen species in photoaging.
M. Dalle Carbonare (1992)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
10.1080/01926230290166724
Invited Review: Oxidation of Biological Systems: Oxidative Stress Phenomena, Antioxidants, Redox Reactions, and Methods for Their Quantification
R. Kohen (2002)
10.1164/AJRCCM.157.5.9707141
Mechanisms in the pathogenesis of asbestosis and silicosis.
B. Mossman (1998)
10.1016/0169-409X(95)00033-4
Long-circulating iron oxides for MR imaging
R. Weissleder (1995)
10.1289/EHP.898139
Response modification in carcinogenesis.
P. Cerutti (1989)
10.1016/S0378-4274(98)00323-3
Cytokines and irritant contact dermatitis.
E. Corsini (1998)
10.1039/B402025A
Magnetic nanoparticle design for medical diagnosis and therapy
S. Mornet (2004)
10.1002/j.1460-2075.1991.tb07761.x
Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.
R. Schreck (1991)
10.1016/S0891-5849(01)00530-5
Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation.
V. Hudson (2001)
10.1016/S1369-7021(01)80035-3
Nanotechniques and approaches in biotechnology
A. Curtis (2001)
Les oxydes de fer comme agents de contraste en IRM hépatique.
B. Beers (1995)
10.1054/MEHY.1999.0011
Selective treatment of neoplastic cells using ferritin-mediated electromagnetic hyperthermia.
M. Babincová (2000)
10.1289/EHP.97105S51159
Cytokines and particle-induced inflammatory cell recruitment.
K. Driscoll (1997)
10.1016/J.COPBIO.2004.11.001
Targeted contrast agents for magnetic resonance imaging and ultrasound.
A. Morawski (2005)
10.1111/1523-1747.EP12395658
Interleukin-8 production is regulated by protein kinase C in human keratinocytes.
M. Chabot-Fletcher (1994)
10.1016/j.taap.2008.09.030
Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line.
N. Monteiro-Riviere (2009)
10.1023/A:1015948505117
The role of AP-1, NF-κB and ROS/NOS in skin carcinogenesis: The JB6 model is predictive
Arindam Dhar (2004)
Development and experimental application of receptor-specific MR contrast media
P Reimer (1996)
10.1148/RADIOLOGY.214.2.R00FE19568
Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model.
A. Moore (2000)
10.1038/281589a0
Tumour promoter induces anchorage independence irreversibly
N. Colburn (1979)
10.3109/02656739609027678
Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro.
A. Jordan (1996)
10.2307/3432205
Oxygen-derived species: their relation to human disease and environmental stress.
B. Halliwell (1994)
10.1111/j.1751-1097.1994.tb04993.x
ULTRAVIOLET LIGHT‐INDUCED FREE RADICAL FORMATION IN SKIN: AN ELECTRON PARAMAGNETIC RESONANCE STUDY
B. Jurkiewicz (1994)
10.1038/nbt1201-1141
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells
J. Bulte (2001)
Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
N. Colburn (1982)
10.1016/S0167-7799(00)01536-5
Nantotechniques and approaches in biotechnology.
A. Curtis (2001)



This paper is referenced by
10.1016/j.bbrep.2017.12.002
Comprehensive cytotoxicity studies of superparamagnetic iron oxide nanoparticles
R. Patil (2018)
10.1002/AOC.4833
Synthesis of Imatinib‐loaded chitosan‐modified magnetic nanoparticles as an anti‐cancer agent for pH responsive targeted drug delivery
Z. K. Ghezeli (2019)
10.1517/13543776.2015.1028358
Iron oxide-based multifunctional nanoparticulate systems for biomedical applications: a patent review (2008 – present)
M. El-Hammadi (2015)
10.1007/s13530-016-0296-7
Toxicity of Fe3O4 nanoparticles on oxidative stress status, stromal enzymes and mitochondrial respiration and swelling of Oryctolagus cuniculus brain cortex
Taib Chahinez (2016)
10.1038/srep29247
Zero-valent Fe confined mesoporous silica nanocarriers (Fe(0) @ MCM-41) for targeting experimental orthotopic glioma in rats
M. Shevtsov (2016)
10.1002/9783527694396.CH13
Magnetic Iron Oxide Nanoparticles: Bioapplications and Potential Toxicity
Hongying Su (2016)
Application of magnetic nanoparticles and reactive filter materials for wastewater treatment
R. Lakshmanan (2013)
10.1002/wnan.1415
Toward RNA nanoparticle vaccines: synergizing RNA and inorganic nanoparticles to achieve immunopotentiation.
R. K. Delong (2017)
10.1002/jbm.b.33450
Effects of iron oxide nanoparticles on biological responses and MR imaging properties in human mammary healthy and breast cancer epithelial cells.
Q. Zhang (2016)
10.1002/wnan.1244
Understanding engineered nanomaterial skin interactions and the modulatory effects of ultraviolet radiation skin exposure.
Samreen Jatana (2014)
10.1007/s11051-012-1091-2
Toxicity of iron oxide nanoparticles against osteoblasts
Sifeng Shi (2012)
10.33915/etd.493
Conceptual Learning: Enhancing Student Understanding of Physiology
Micah J. Waltz (2014)
10.1088/0957-4484/26/50/505101
Antitumor activity and systemic effects of PVM/MA-shelled selol nanocapsules in lung adenocarcinoma-bearing mice.
Ludmilla Regina de Souza (2015)
10.1002/jat.3485
Iron oxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in lymphocytes
Usha Singh Gaharwar (2017)
10.1007/978-981-15-1702-0
Model Organisms to Study Biological Activities and Toxicity of Nanoparticles
B. Siddhardha (2020)
10.1039/C5EN00016E
Assessment of functionalized iron oxide nanoparticles in vitro: introduction to integrated nanoimpact index
Narges Bayat (2015)
10.1016/j.colsurfb.2017.11.003
Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma.
S. Saesoo (2018)
Molecular imaging and gene therapy in experimental arthritis: a luminescent future for targeted therapy?
Eline A. Vermeij (2016)
10.1016/J.JPCS.2019.06.016
Biocompatible and high-magnetically responsive iron oxide nanoparticles for protein loading
A. Gaspar (2019)
10.3390/antiox9030191
Utilizing Iron for Targeted Lipid Peroxidation as Anticancer Option of Integrative Biomedicine: A Short Review of Nanosystems Containing Iron
M. Jaganjac (2020)
10.1039/c3cs60064e
Cytokines as biomarkers of nanoparticle immunotoxicity.
Mahmoud Elsabahy (2013)
10.1016/j.actbio.2013.05.022
Endocytotic uptake of iron oxide nanoparticles by cultured brain microglial cells.
E. M. Luther (2013)
10.1007/978-3-319-72041-8_6
Nanoparticles-Caused Oxidative Imbalance.
M. Żuberek (2018)
10.1016/j.fct.2019.110989
Genotoxicity and biocompatibility of superparamagnetic iron oxide nanoparticles: Influence of surface modification on biodistribution, retention, DNA damage and oxidative stress.
S. Ghosh (2019)
10.3762/bjnano.5.245
Interaction of dermatologically relevant nanoparticles with skin cells and skin
A. Vogt (2014)
10.1021/acsami.7b15116
Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells.
Sebastian Pernal (2017)
10.1021/acsnano.7b03519
Photoacoustic Imaging of Human Mesenchymal Stem Cells Labeled with Prussian Blue-Poly(l-lysine) Nanocomplexes.
Tae-Ho Kim (2017)
10.1186/s12951-014-0063-3
Effects of an 11-nm DMSA-coated iron nanoparticle on the gene expression profile of two human cell lines, THP-1 and HepG2
Ling Zhang (2015)
10.1016/j.taap.2016.01.019
A redox proteomics approach to investigate the mode of action of nanomaterials.
C. Riebeling (2016)
Understanding Engineered Nanomaterial Skin Interactions and the Modulatory Effects of UVR Skin Exposure
Samreen Jatana (2015)
10.1021/am503068r
Bioconjugated iron oxide nanocubes: synthesis, functionalization, and vectorization.
L. Wortmann (2014)
10.1371/journal.pone.0110573
Galvanic Manufacturing in the Cities of Russia: Potential Source of Ambient Nanoparticles
K. Golokhvast (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar